PL2935274T3 - Pochodne 3-okso-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pirymidyny do leczenia chorób układu oddechowego - Google Patents
Pochodne 3-okso-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pirymidyny do leczenia chorób układu oddechowegoInfo
- Publication number
- PL2935274T3 PL2935274T3 PL13826565T PL13826565T PL2935274T3 PL 2935274 T3 PL2935274 T3 PL 2935274T3 PL 13826565 T PL13826565 T PL 13826565T PL 13826565 T PL13826565 T PL 13826565T PL 2935274 T3 PL2935274 T3 PL 2935274T3
- Authority
- PL
- Poland
- Prior art keywords
- triazolo
- tetrahydro
- oxo
- treatment
- respiratory diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
- C07C309/08—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/20—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
- C07C47/19—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/02—Formic acid
- C07C53/06—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12197767 | 2012-12-18 | ||
| EP13158757 | 2013-03-12 | ||
| EP13826565.7A EP2935274B1 (en) | 2012-12-18 | 2013-12-16 | 3-oxo-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine derivatives for the treatmetn of respiratory diseases |
| PCT/EP2013/076672 WO2014095700A1 (en) | 2012-12-18 | 2013-12-16 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2935274T3 true PL2935274T3 (pl) | 2019-04-30 |
Family
ID=50030225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13826565T PL2935274T3 (pl) | 2012-12-18 | 2013-12-16 | Pochodne 3-okso-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pirymidyny do leczenia chorób układu oddechowego |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US9365577B2 (pl) |
| EP (1) | EP2935274B1 (pl) |
| JP (1) | JP6390919B2 (pl) |
| KR (1) | KR102197721B1 (pl) |
| CN (1) | CN104870449B (pl) |
| AU (1) | AU2013363783B2 (pl) |
| BR (1) | BR112015014438B1 (pl) |
| CA (1) | CA2895352C (pl) |
| CL (1) | CL2015001678A1 (pl) |
| CY (1) | CY1122368T1 (pl) |
| DK (1) | DK2935274T3 (pl) |
| EA (1) | EA028507B1 (pl) |
| ES (1) | ES2700226T3 (pl) |
| GE (2) | GEP20186885B (pl) |
| HR (1) | HRP20182007T1 (pl) |
| IL (1) | IL239447B (pl) |
| LT (1) | LT2935274T (pl) |
| MX (1) | MX2015007379A (pl) |
| NZ (1) | NZ709153A (pl) |
| PE (1) | PE20151084A1 (pl) |
| PH (1) | PH12015501043A1 (pl) |
| PL (1) | PL2935274T3 (pl) |
| PT (1) | PT2935274T (pl) |
| RS (1) | RS58129B1 (pl) |
| SA (1) | SA515360612B1 (pl) |
| SG (2) | SG10201703484YA (pl) |
| SI (1) | SI2935274T1 (pl) |
| TN (1) | TN2015000276A1 (pl) |
| TW (1) | TWI675837B (pl) |
| UA (1) | UA118021C2 (pl) |
| WO (1) | WO2014095700A1 (pl) |
| ZA (1) | ZA201504331B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| TW201517906A (zh) | 2013-07-25 | 2015-05-16 | Almirall Sa | 含有ｍａｂａ化合物和皮質類固醇之組合 |
| KR20160097227A (ko) * | 2013-12-16 | 2016-08-17 | 키에시 파르마슈티시 엣스. 피. 에이. | 인간 호중구 엘라스타제 억제제로서 테트라하이드로트리아졸로피리미딘 유도체 |
| US9487528B2 (en) | 2014-06-09 | 2016-11-08 | Chiesi Farmaceutici S.P.A. | Compounds |
| TR201811041T4 (tr) * | 2014-06-12 | 2018-08-27 | Chiesi Farm Spa | Yeni̇ bi̇leşi̇kler. |
| US9657015B2 (en) | 2014-07-31 | 2017-05-23 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
| US9475779B2 (en) | 2014-07-31 | 2016-10-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
| TW201617343A (zh) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物 |
| US9890169B2 (en) | 2015-12-14 | 2018-02-13 | Chiesi Farmaceutici S.P.A. | Triazolinone compounds as HNE inhibitors |
| UA123109C2 (uk) | 2016-05-31 | 2021-02-17 | К'Єзі Фармачеутічі С.П.А. | Сполуки імідазолону як інгібітори нейтрофіл-еластази людини |
| AR108608A1 (es) | 2016-05-31 | 2018-09-05 | Chiesi Farm Spa | Derivados de pirazolil carbonilo inhibidores de ahr |
| EP3464269B1 (en) | 2016-05-31 | 2020-04-01 | Chiesi Farmaceutici S.p.A. | Heterocyclic compounds for use in the treatment of a hne related disease |
| JP7368065B2 (ja) | 2018-10-30 | 2023-10-24 | キエージィ ファーマチェウティチ エス．ペー．アー． | 人工呼吸器を装着している患者に薬物を投与するための装置 |
| KR102898819B1 (ko) | 2019-09-24 | 2025-12-12 | 키에시 파르마슈티시 엣스. 피. 에이. | 흡입용 건조 분말 제제를 위한 신규 담체 입자 |
| US20250051340A1 (en) | 2021-12-22 | 2025-02-13 | Chiesi Farmaceutici S.P.A. | Triazolone derivative salt as neutrophil elastase inhibitor |
| MX2024007587A (es) | 2021-12-22 | 2024-07-04 | Chiesi Farm Spa | Sal derivada de triazolona como inhibidor de elastasa de neutrofilos. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| AR006401A1 (es) * | 1996-03-28 | 1999-08-25 | Glaxo Group Ltd | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. |
| GB0608844D0 (en) * | 2006-05-04 | 2006-06-14 | Argenta Discovery Ltd | Enzyme inhibitors |
| DE102009004197A1 (de) * | 2009-01-09 | 2010-07-15 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung |
| GB201004179D0 (en) * | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
| GB201004178D0 (en) * | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
| TWI568735B (zh) * | 2011-09-14 | 2017-02-01 | 吉斯藥品公司 | 新穎化合物 |
-
2013
- 2013-12-16 EP EP13826565.7A patent/EP2935274B1/en active Active
- 2013-12-16 SI SI201331244T patent/SI2935274T1/sl unknown
- 2013-12-16 MX MX2015007379A patent/MX2015007379A/es active IP Right Grant
- 2013-12-16 LT LTEP13826565.7T patent/LT2935274T/lt unknown
- 2013-12-16 TW TW102146370A patent/TWI675837B/zh active
- 2013-12-16 DK DK13826565.7T patent/DK2935274T3/en active
- 2013-12-16 PE PE2015000931A patent/PE20151084A1/es unknown
- 2013-12-16 SG SG10201703484YA patent/SG10201703484YA/en unknown
- 2013-12-16 CN CN201380065981.1A patent/CN104870449B/zh active Active
- 2013-12-16 GE GEAP201313860A patent/GEP20186885B/en unknown
- 2013-12-16 JP JP2015547060A patent/JP6390919B2/ja active Active
- 2013-12-16 WO PCT/EP2013/076672 patent/WO2014095700A1/en not_active Ceased
- 2013-12-16 RS RS20181517A patent/RS58129B1/sr unknown
- 2013-12-16 PT PT13826565T patent/PT2935274T/pt unknown
- 2013-12-16 CA CA2895352A patent/CA2895352C/en active Active
- 2013-12-16 EA EA201590962A patent/EA028507B1/ru unknown
- 2013-12-16 SG SG11201504737RA patent/SG11201504737RA/en unknown
- 2013-12-16 UA UAA201505958A patent/UA118021C2/uk unknown
- 2013-12-16 NZ NZ709153A patent/NZ709153A/en unknown
- 2013-12-16 KR KR1020157016352A patent/KR102197721B1/ko active Active
- 2013-12-16 PL PL13826565T patent/PL2935274T3/pl unknown
- 2013-12-16 AU AU2013363783A patent/AU2013363783B2/en active Active
- 2013-12-16 BR BR112015014438-1A patent/BR112015014438B1/pt active IP Right Grant
- 2013-12-16 HR HRP20182007TT patent/HRP20182007T1/hr unknown
- 2013-12-16 GE GEAP201813860A patent/GEAP201813860A/en unknown
- 2013-12-16 ES ES13826565T patent/ES2700226T3/es active Active
- 2013-12-17 US US14/108,904 patent/US9365577B2/en active Active
-
2015
- 2015-05-11 PH PH12015501043A patent/PH12015501043A1/en unknown
- 2015-06-15 ZA ZA2015/04331A patent/ZA201504331B/en unknown
- 2015-06-16 CL CL2015001678A patent/CL2015001678A1/es unknown
- 2015-06-16 IL IL239447A patent/IL239447B/en active IP Right Grant
- 2015-06-16 TN TNP2015000276A patent/TN2015000276A1/fr unknown
- 2015-06-17 SA SA515360612A patent/SA515360612B1/ar unknown
-
2016
- 2016-05-10 US US15/150,749 patent/US9828382B2/en active Active
-
2018
- 2018-11-07 CY CY20181101168T patent/CY1122368T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2935274T3 (pl) | Pochodne 3-okso-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pirymidyny do leczenia chorób układu oddechowego | |
| HUS1900040I1 (hu) | Makrociklusos származékok proliferatív betegségek kezelésére | |
| IL264402B (en) | History of pyrrolo(2,3–d)pyrimidine for the treatment of viral infections and other diseases | |
| IL237761B (en) | History of pyrrolo[2,3–d]pyrimidine for the treatment of viral infections and other diseases | |
| IL235659A (en) | History 3, 4 - Dihydro-h2 - Pyrido [1, 2 - a] Pyrazine – 1, 6 - Transformed deion used to treat (among other things) Alzheimer's disease | |
| DK3418281T3 (da) | Pyrazolo[1,5-a]pyrimidiner, der er anvendelige som inhibitorer af atr-kinase til behandling af cancersygdomme | |
| IL243092A0 (en) | New triazolo[d–4,5]pyrimidine histories | |
| SG11201605207PA (en) | Pyrazolo[1,5-a]pyridine derivatives and methods of their use | |
| ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
| HRP20182021T1 (hr) | Derivati [1,2,4]triazolo[1,5-a]pirimidina kao inhibitori proteazoma protozoe za liječenje parazitskih bolesti poput lišmenijaze | |
| PL395469A1 (pl) | Pochodne indoloamin do leczenia chorób osrodkowego ukladu nerwowego |